Literature DB >> 22965325

Blood transfusion is an important predictor of hospital mortality among patients with aneurysmal subarachnoid hemorrhage.

Emir Festic1, Alejandro A Rabinstein, William D Freeman, Elizabeth A Mauricio, Maisha T Robinson, Jay Mandrekar, Abba C Zubair, Augustine S Lee, Ognjen Gajic.   

Abstract

BACKGROUND: Red blood cell (RBC) transfusion after aneurysmal subarachnoid hemorrhage (aSAH) has been associated with increased mortality but prior studies have not adequately adjusted for transfusion-indication bias.
METHODS: This is a retrospective study of consecutive aSAH patients admitted to the intensive care units of two academic medical centers over a 7-year period. Data collection included demographics, World Federation of Neurosurgical Surgeons score (WFNS), modified Fisher score (mFisher), admission and nadir hemoglobin (Hb) level, vasospasm, cerebral infarction, acute lung injury, and hospital mortality. The association between RBC transfusion and mortality was evaluated using a multivariate logistic regression analysis using the propensity for RBC transfusion as a covariate.
RESULTS: We identified 318 patients. The median age was 54 years (46, 65), and 204 (64 %) were females. Hospital mortality was 13 % (42/318). Seventy-two (23 %) patients were transfused. Predictors of transfusion were admit and nadir Hb levels (p < 0.001), age (p = 0.02), gender (0.008), WFNS score (p < 0.001), mFisher score (p = 0.009), surgical versus endovascular treatment (p < 0.001) and moderate to severe vasospasm (p = 0.025) were predictors of transfusion. After adjustment for probability of receiving RBC transfusion, APACHE IV and nadir Hb, transfusion remained independently associated with hospital mortality (OR 3.16, 95 % CI = 1.02-9.69, p = 0.047).
CONCLUSIONS: Among patients with aSAH, RBC transfusion was independently associated with an increased mortality after adjustment for the most common clinical indications for transfusion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22965325     DOI: 10.1007/s12028-012-9777-y

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  29 in total

1.  Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions.

Authors:  Paul C Hébert; Dean Fergusson; Morris A Blajchman; George A Wells; Andrew Kmetic; Doug Coyle; Nancy Heddle; Marc Germain; Mindy Goldman; Baldwin Toye; Irwin Schweitzer; Carl vanWalraven; Dana Devine; Graham D Sher
Journal:  JAMA       Date:  2003-04-16       Impact factor: 56.272

Review 2.  Clinical consequences of red cell storage in the critically ill.

Authors:  Alan Tinmouth; Dean Fergusson; Ian Chin Yee; Paul C Hébert
Journal:  Transfusion       Date:  2006-11       Impact factor: 3.157

Review 3.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

4.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

5.  Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage.

Authors:  Andrew M Naidech; Jessica Drescher; Michael L Ault; Ali Shaibani; H Hunt Batjer; Mark J Alberts
Journal:  Neurosurgery       Date:  2006-10       Impact factor: 4.654

6.  Improvement in intensive care unit outcomes in patients with subarachnoid hemorrhage after initiation of neurointensivist co-management.

Authors:  S Andrew Josephson; Vanja C Douglas; Michael T Lawton; Joey D English; Wade S Smith; Nerissa U Ko
Journal:  J Neurosurg       Date:  2010-03       Impact factor: 5.115

7.  The effect of hemodilution on cerebral blood flow velocity in anesthetized patients.

Authors:  N Bruder; B Cohen; D Pellissier; G François
Journal:  Anesth Analg       Date:  1998-02       Impact factor: 5.108

8.  Mortality rates after subarachnoid hemorrhage: variations according to hospital case volume in 18 states.

Authors:  DeWitte T Cross; David L Tirschwell; Mary Ann Clark; Dan Tuden; Colin P Derdeyn; Christopher J Moran; Ralph G Dacey
Journal:  J Neurosurg       Date:  2003-11       Impact factor: 5.115

9.  The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States.

Authors:  Howard L Corwin; Andrew Gettinger; Ronald G Pearl; Mitchell P Fink; Mitchell M Levy; Edward Abraham; Neil R MacIntyre; M Michael Shabot; Mei-Sheng Duh; Marc J Shapiro
Journal:  Crit Care Med       Date:  2004-01       Impact factor: 7.598

10.  Impact of medical complications on outcome after subarachnoid hemorrhage.

Authors:  Katja E Wartenberg; J Michael Schmidt; Jan Claassen; Richard E Temes; Jennifer A Frontera; Noeleen Ostapkovich; Augusto Parra; E Sander Connolly; Stephan A Mayer
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

View more
  12 in total

1.  Red blood cell transfusion in acute brain injury subtypes: An observational cohort study.

Authors:  Rajat N Moman; Daryl J Kor; Arun Chandran; Andrew C Hanson; Darrell R Schroeder; Alejandro A Rabinstein; Matthew A Warner
Journal:  J Crit Care       Date:  2018-11-11       Impact factor: 3.425

2.  RBC Transfusion Improves Cerebral Oxygen Delivery in Subarachnoid Hemorrhage.

Authors:  Rajat Dhar; Allyson R Zazulia; Colin P Derdeyn; Michael N Diringer
Journal:  Crit Care Med       Date:  2017-04       Impact factor: 7.598

3.  The Effect of Packed Red Blood Cell Transfusion on Cerebral Oxygenation and Metabolism After Subarachnoid Hemorrhage.

Authors:  Pedro Kurtz; Raimund Helbok; Jan Claassen; J Michael Schmidt; Luis Fernandez; R Morgan Stuart; E Sander Connolly; Kiwon Lee; Stephan A Mayer; Neeraj Badjatia
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

4.  Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?

Authors:  Tyree H Kiser
Journal:  Hosp Pharm       Date:  2014-11

5.  Seven deadly sins in trauma outcomes research: an epidemiologic post mortem for major causes of bias.

Authors:  Deborah J del Junco; Erin E Fox; Elizabeth A Camp; Mohammad H Rahbar; John B Holcomb
Journal:  J Trauma Acute Care Surg       Date:  2013-07       Impact factor: 3.313

Review 6.  Red blood cell transfusion in neurosurgical patients.

Authors:  Shaun E Gruenbaum; Keith J Ruskin
Journal:  Curr Opin Anaesthesiol       Date:  2014-10       Impact factor: 2.706

7.  Genetic Variability and Trajectories of DNA Methylation May Support a Role for HAMP in Patient Outcomes After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Lacey W Heinsberg; Annie I Arockiaraj; Elizabeth A Crago; Dianxu Ren; John R Shaffer; Paula R Sherwood; Susan M Sereika; Daniel E Weeks; Yvette P Conley
Journal:  Neurocrit Care       Date:  2020-04       Impact factor: 3.210

Review 8.  Management of delayed cerebral ischemia after subarachnoid hemorrhage.

Authors:  Charles L Francoeur; Stephan A Mayer
Journal:  Crit Care       Date:  2016-10-14       Impact factor: 9.097

9.  The critical care management of poor-grade subarachnoid haemorrhage.

Authors:  Airton Leonardo de Oliveira Manoel; Alberto Goffi; Tom R Marotta; Tom A Schweizer; Simon Abrahamson; R Loch Macdonald
Journal:  Crit Care       Date:  2016-01-23       Impact factor: 9.097

Review 10.  Anemia management after acute brain injury.

Authors:  Christophe Lelubre; Pierre Bouzat; Ilaria Alice Crippa; Fabio Silvio Taccone
Journal:  Crit Care       Date:  2016-06-17       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.